'Fast Money' Recap: Should You Invest in Ebola Vaccine Developers?
at The Street - 2 hrs 5 mins ago
The trading panel discussed what the first U.S. case of Ebola means to drug companies and whether to gamble on casinos.
Market Maker Surveillance Report. APT, SPEX, TKMR, NSPR, ANGI, CBDE, Winning Stocks With Lowest Price Friction For Tuesday, September 30th 2014
M2 - 2 hrs 9 mins ago
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4716 companies with "abnormal" market making, 1613 companies with positive Friction Factors and 3632 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Alpha Pro Tech Ltd (NYSE:APT), Spherix Inc (NASDAQ:SPEX), TEKMIRA PHARMACEUTICALS CORP (NASDAQ:TKMR), InspireMD Inc (OTC:NSPR), Angie's List Inc (NASDAQ:ANGI), (NASDAQ:CBDE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Shares of companies testing Ebola vaccines rise
AP - Tue Sep 30, 5:58PM CDT
NEW YORK (AP) — Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining in After-Hours Trading Today
at The Street - Tue Sep 30, 4:11PM CDT
Tekmira Pharmaceuticals (TKMR) shares are climbing following the news that the first case of Ebola has been confirmed in the U.S.
'Mad Money' Lightning Round: I'm Not Very Happy With Oracle
at The Street - Tue Sep 30, 5:00AM CDT
Cramer is no fan of Annaly Capital but does like Opko Health and Dow Chemical.
Jim Cramer's 'Mad Money' Recap: Use the Volatility to Make More Money
at The Street - Mon Sep 29, 7:13PM CDT
Lighten up on your holdings the next time the market soars so you can buy them back at lower prices during the next inevitable selloff, Cramer advises.
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios
at The Street - Fri Sep 26, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Nasdaq stocks posting largest percentage decreases
AP - Thu Sep 25, 12:24PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics
PR Newswire - Thu Sep 25, 8:20AM CDT
Today, Analysts Review released its research reports regarding Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and United Therapeutics Corporation (NASDAQ: UTHR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6765-100free.
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver
PR Newswire - Wed Sep 24, 9:37AM CDT
InvestorsObserver issues critical PriceWatch Alerts for TKMR, HLF, AA, ACT and TWTR.
'Fast Money' Recap: How to Play the Falling Market
at The Street - Wed Sep 24, 4:00AM CDT
The trading panel discussed whether the Alibaba IPO is affecting the markets and whether Apple shares will decline.
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa
GlobeNewswire - Tue Sep 23, 5:09AM CDT
Consortium Receives £3.2 Million Funding From Wellcome Trust
Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor
at The Street - Mon Sep 22, 6:48PM CDT
Ebola patient Dr. Rick Sacra received treatment with Tekmira Pharmaceuticals' experimental ebola therapy TKM-Ebola for seven days, Nebraska Medical Center confirmed.
Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today
at The Street - Mon Sep 22, 11:02AM CDT
Tekmira Pharmaceuticals (TKMR) shares are up double digits after the company announced that it received regulatory approval to administer its Ebola treatment.
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola
GlobeNewswire - Mon Sep 22, 8:53AM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access protocols to subjects with confirmed or suspected Ebola virus infections.
Ebola-Stricken Doc Receives Experimental Drug, But Which One?
at The Street - Thu Sep 11, 1:20PM CDT
Twitter abuzz with speculation that Tekmira's experimental Ebola therapy is being used to treat patient.
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity
at The Street - Wed Sep 10, 8:36AM CDT
The Ebola outbreak in West Africa is a public health emergency which has also captured the attention of U.S. investors (perhaps I should say traders.)